"The Commission of Human Medicines (CHM) has been asked to review the safety of ibuprofen in patients with COVID-19. The Commission on Human Medicines’ Expert Working Group on coronavirus (COVID-19) has concluded that there is currently insufficient evidence to establish a link between use of ibuprofen, or other non-steroidal anti-inflammatory drugs (NSAIDs), and contracting or worsening of COVID-19."
Letter dated 14.04.2020 from NHS England Medical Director on anti-inflammatory medications and correspondence from the Pharmacy and Medicines Division of the Scottish CMO Directorate referring to the same.